Division of Infectious Disease
Department of Medicine
Patient Care + Clinical Services
Kids Rarely Transmit COVID-19, Say Pediatric Infectious Disease Experts Lee and Raszka
A commentary published in the journal Pediatrics by Benjamin Lee, M.D. and William V. Raszka, Jr., M.D., concludes that children infrequently transmit COVID-19 to each other or to adults and that many schools, provided they follow appropriate social distancing guidelines and take into account rates of transmission in their community, can and should reopen in the fall.
Kirkpatrick Quoted in Two ABC News Stories on COVID-19 Vaccine & Antibodies
(JUNE 19 & 24, 2020) Beth Kirkpatrick, M.D., chair of microbiology and molecular genetics and director of the Vaccine Testing Center, was quoted in two ABCNews.com stories - one on a potential COVID-19 vaccine and the other on the durability of COVID-19 antibodies.
TGIR Hosts Virus "Slam" on 2019-nCoV
University of Vermont scientists, physicians, and students gathered at the Larner College of Medicine February 6 for the first-ever on-campus “virus slam” hosted by the Translational Global Infectious Diseases Research Center. At the event, some twenty experts, from five UVM colleges and institutes, gave five-minute mini-talks that ranged from explaining the biochemistry of the virus’ interaction with the human immune system to interpreting the latest data from the World Health Organization.
Research Excellence and Scholarship Highlighted at Annual Celebration Events
The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
Innovative Research Model Sheds Light on Immune Response in Dengue Infection
Investigators in UVM's Vaccine Testing Center and Center for Translational Global Infectious Disease Research (TGIR) have uncovered details of the human immune response to infection with dengue - a close "cousin" of the Zika virus - which 40 percent of the global population is at risk for contracting. Their study findings were reported recently in the Lancet’s open-access journal EBioMedicine.
$12.3 Million NIH Grant Establishes Translational Global Infectious Disease Research Center
Leaders at the University of Vermont and Larner College of Medicine announced $12.3 million in funding for a new Center of Biomedical Research Excellence (COBRE) called the “Translational Global Infectious Disease Research Center” (TGIR) that will join together two traditionally distinct groups of scientists to develop innovative approaches to prevent and control infectious disease.
Vaccine Testing Center a Site for New NIH Live, Attenuated Zika Vaccine Trial
Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md., and at the Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington.
Kirkpatrick Appointed Chair of Microbiology and Molecular Genetics
Beth Kirkpatrick, M.D., has been appointed as chair of the Department of Microbiology and Molecular Genetics at the University of Vermont, effective March 1, 2018.
Diehl and Scarpino Receive Inugural UVM Biomedical Engineering Pilot Research Grant
Researchers Sean Diehl, Ph.D., assistant professor of medicine and a Vaccine Testing Center immunologist, and Sam Scarpino, Ph.D., assistant professor of mathematics and statistics, have been awarded the inaugural University of Vermont Biomedical Engineering Program Pilot Research Program grant for their project, “Integrating omics and clinical data to study dengue infection.”
Lyon Leads Trial to Test Vaccine Aimed to Protect Military Troops
Acute respiratory disease (ARD) due to infection with adenovirus is a major cause of morbidity at military training centers. In addition to ARD, adenovirus infection can cause sore throat, pneumonia, conjunctivitis, and urinary infections.
Diehl and Pierce Discuss Dengue Vaccine & Zika at Community Medical School 11/1
According to an October 11 "Viewpoint" article in theJournal of the American Medical Association, "nearly 1700 cases of travel-associated Zika infection, including 479 in pregnant women, had been reported in the continental United States" as of August 4, 2016.
UVM Clinical Trials Lead to First FDA Approved Cholera Vaccine in U.S.
Cholera outbreaks continue to plague areas like South Sudan, Eastern Uganda, and Kerala, India, but there’s hope for addressing this infectious disease: Last month, the Food and Drug Administration approved the only vaccine for use in the U.S. to protect against cholera infection. The University of Vermont’s Vaccine Testing Center was one of three national sites to test the vaccine – called Vaxchora – for effectiveness.
Kirkpatrick and Colleagues’ Study Reveals Effective, Single-Dose Dengue Vaccine
Researchers at the University of Vermont (UVM) Vaccine Testing Center, along with collaborators at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health and Johns Hopkins Bloomberg School of Public Health, have been working since 2008 to develop a dengue vaccine that will protect against all four dengue strains.
Vaccine Testing Center Receives Funding to Advance New Treatments for Parasitic Infection
Limited treatment options and no vaccines exist to treat or prevent a leading cause of severe diarrhea in infants and young children in the developing world: Cryptosporidium, a single-celled intestinal parasite found in soil, food and water that also causes significant illness and death in immunocompromised individuals.
UVM Vaccine Testing Center to Play Role in Zika Virus Vaccine; Experts Answer Questions
The University of Vermont Vaccine Testing Center has announced that it will be involved in the clinical trials and research on a vaccine for Zika virus, which was declared a global health emergency by the World Health Organization on February 1, 2016.
Lee Earns Hood Foundation Grant for Rotavirus Vaccine Research in Bangladesh
University of Vermont researcher Benjamin Lee, M.D., is studying whether a higher dose will help make the rotavirus vaccine more effective in developing countries, where the disease causes more than 200,000 children’s deaths each year due to related dehydration.
UVM Vaccine Testing Center Featured in Multiple Media Outlets for Role in Zika Virus Vaccine
A recent announcement that the UVM Vaccine Testing Center will be involved in the clinical trials and research on a vaccine for Zika virus, which was declared a global health emergency by the World Health Organization on February 1, 2016, attracted wide local and regional media coverage. Read more from
ABC 22/Fox 44 News
WCAX-TV CBS 3
WPTZ-TV NBC 5
Vermont Business Magazine
St. Albans Messenger
WCAX-TV CBS 3 HealthWatch
U.S. News Hub
Killington Mountain Times
Burlington Sun Times
Vermont Public Radio Here and Now
, Press Telegraph (no longer available),
The Robert Larner, M.D. College of Medicine
University of Vermont
University of Vermont Medical Center
Copyright 2023 | Burlington, VT